PPC
ZBH icon

Park Place Capital’s Zimmer Biomet ZBH Stock Holding History

Park Place Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12
Closed -$1.58K – 934
2024
Q1 		$1.58K Sell
12
-81
-87% -$10.1K ﹤0.01% 850
2023
Q4 		$11.3K Buy
+93
New +$10.4K ﹤0.01% 609
2023
Q1 		– Sell
-7
Closed -$1K – 1053
2022
Q4 		$1K Buy
+7
New +$812 ﹤0.01% 1024

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Park Place Capital's ZBH Position: Q2 2024 in Review

Park Place Capital sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 12 shares — an estimated $1.58K sold.

Park Place Capital first reported a position in ZBH in Q4 2022 and held it in 3 quarters. The position peaked at $11.3K in Q4 2023. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Park Place Capital reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • Park Place Capital sold 12 Zimmer Biomet shares in Q2 2024, an estimated $1.58K.
  • Park Place Capital first reported a position in Zimmer Biomet in Q4 2022 and held it in 3 quarters.
  • Park Place Capital's Zimmer Biomet position peaked at $11.3K in Q4 2023.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Park Place Capital's 13F filing for Q2 2024, filed 2 Jul 2024.